Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 5

Advertisement Combining open-access publishing with a powerful networking platform. The Frontiers publication process and Research Networking Platform allow you to build your own scientific profiles while following the work of colleagues, mentors and your science heroes. Connect with your community today TABLE OF CONTENTS Volume 20, Issue 5 (May 2013) In this issue Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Wondering where to publish your next paper? Frontiers is a community-oriented open-access publisher and research network. We are driving innovations around peer-review and a whole ecosystem of open science tools Be a part of the future of research publication   Original Articles Top Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy H V Reddi, C B Driscoll, P Madde, D Milosevic, R M Hurley, S J McDonough, J Hallanger-Johnson, B McIver and N L Eberhardt Cancer Gene Ther 2013 20: 267-275; advance online publication, April 19, 2013; 10.1038/cgt.2013.16 Abstract | Full Text Expression of β-glucuronidase on the surface of bacteria enhances activation of glucuronide prodrugs C-M Cheng, F M Chen, Y-L Lu, S-C Tzou, J-Y Wang, C-H Kao, K-W Liao, T-C Cheng, C-H Chuang, B-M Chen, S Roffler and T-L Cheng Cancer Gene Ther 2013 20: 276-281; advance online publication, April 19, 2013; 10.1038/cgt.2013.17 Abstract | Full Text Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtype B P Cuddington, A L Dyer, S T Workenhe and K L Mossman Cancer Gene Ther 2013 20: 282-289; advance online publication, April 26, 2013; 10.1038/cgt.2013.18 Abstract | Full Text Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma B-F Yu, J Wu, Y Zhang, H-W Sung, J Xie and R-K Li Cancer Gene Ther 2013 20: 290-297; advance online publication, April 19, 2013; 10.1038/cgt.2013.19 Abstract | Full Text Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer C Miceli, A Tejada, A Castaneda and S J Mistry Cancer Gene Ther 2013 20: 298-307; advance online publication, April 26, 2013; 10.1038/cgt.2013.21 Abstract | Full Text The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy Y-F Huang, M-J Chen, M-H Wu and S-C Hung Cancer Gene Ther 2013 20: 308-316; advance online publication, April 26, 2013; 10.1038/cgt.2013.22 Abstract | Full Text Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo C A Merkel, R F V Medrano, V G Barauna and B E Strauss Cancer Gene Ther 2013 20: 317-325; advance online publication, April 26, 2013; 10.1038/cgt.2013.23 Abstract | Full Text Short Communication Top Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation A Malek, B Gyorffy, C V Catapano and R Schäfer Cancer Gene Ther 2013 20: 326-329; advance online publication, April 26, 2013; 10.1038/cgt.2013.20 Abstract | Full Text Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.